Diane M. Simeone, MD, Laura and Issac Perlmutter Professor of Surgery in the Department of Surgery; professor in the Department of Pathology; associate director of Translational Research at Perlmutter Cancer Center; professor in the Department of Pathology at NYU Grossman School of Medicine; and director of the Pancreatic Cancer Center of NYU Langone Health, discusses the importance of germline testing in pancreatic cancer.
All patients with pancreatic cancer should receive germline testing, says Simeone. Germline testing helps physicians to identify family members who might be at risk and help said family members undergo the screening they need. Watch here . . .